MN

Manish Naranbhai Raval

Active Director Director DIN 01462977
DIN 01462977 First appointment May 2007 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since May 2007
Shareholding value •••• Premium profile

About Manish Naranbhai Raval

Data last updated:

Manish Naranbhai Raval is a Director at Niva Aks Life Sciences Private Limited (since 2007), Partner at Haides Ventures Llp (since 2022) and Designated Partner at Vrajshree Multispeciality Hospital Llp (since 2023). The companies operate in Healthcare and Real Estate and Construction. The 2 current companies with reported revenue have a combined latest revenue of ₹2.70 Cr; the largest is Niva Aks Life Sciences Private Limited at ₹2.70 Cr (FY 2024). Earlier, Manish Naranbhai Raval was a Director at Kinvasc Products Private Limited (from 2013) and Director at Venous Clinics Private Limited (from 2013).

DIN 01462977
Primary Designation Director
Industry Healthcare
First Appointment 19 May 2007
Oldest Company Age 19 yrs
Largest company Niva Aks Life Sciences Private Limited · ₹2.70 Cr (FY 2024)
Combined revenue ₹2.70 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 May 20072007₹2.70 Cr (FY 2024)Active
Partner21 Nov 20222022₹7,271 (FY 2026)Active
Designated Partner30 Oct 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kinvasc Products Private Limited U52310GJ2013PTC074634
Director22 Apr 20132013₹19,420 (FY 2021)Strike Off
Venous Clinics Private Limited U85110GJ2013PTC074864
Director03 May 20132013₹81,707 (FY 2018)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vrajshree Multispeciality Hospital Llp
Niva Aks Life Sciences Private Limited
Kinvasc Products Private Limited
Venous Clinics Private Limited
Premium access

Shareholding and investment profile for Manish Naranbhai Raval

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manish Naranbhai Raval

Manish Naranbhai Raval currently holds 3 directorships: Niva Aks Life Sciences Private Limited (Director, since 19 May 2007, revenue ₹2.70 Cr (FY 2024)); Haides Ventures Llp (Partner, since 21 Nov 2022, revenue ₹7,271 (FY 2026)); Vrajshree Multispeciality Hospital Llp (Designated Partner, since 30 Oct 2023).

Manish Naranbhai Raval was first appointed on 19 May 2007 as Director at Niva Aks Life Sciences Private Limited. The most recent appointment on record is 30 Oct 2023 at Vrajshree Multispeciality Hospital Llp.

The 2 current companies of Manish Naranbhai Raval that report revenue have a combined latest revenue of ₹2.70 Cr: Niva Aks Life Sciences Private Limited ₹2.70 Cr (FY 2024); Haides Ventures Llp ₹7,271 (FY 2026).

Manish Naranbhai Raval held 2 earlier board appointments: Kinvasc Products Private Limited (Director, from 22 Apr 2013); Venous Clinics Private Limited (Director, from 03 May 2013).

The current boards of Manish Naranbhai Raval's companies include Avani Manish Raval (Niva Aks Life Sciences Private Limited), Aasit Vinaykant Shah (Haides Ventures Llp), Mehul Parikh (Haides Ventures Llp), Sheetal Aasit Shah (Haides Ventures Llp), Binduben Mehulbhai Raval (Vrajshree Multispeciality Hospital Llp), Harshbhai Navinchandra Raval (Vrajshree Multispeciality Hospital Llp), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available